{"name":"Hopital Foch","slug":"hopital-foch","ticker":"","exchange":"","domain":"","description":"Hopital Foch is a leading healthcare institution with a strong focus on clinical research and patient care, contributing significantly to the advancement of medical treatments and therapies.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"oncology","drugs":[{"name":"Rituximab Injection","genericName":"Rituximab Injection","slug":"rituximab-injection","indication":"Other","status":"marketed"},{"name":"Gelatin 500 mL","genericName":"Gelatin 500 mL","slug":"gelatin-500-ml","indication":"Other","status":"marketed"},{"name":"Propofol Fresenius plus lidocaine","genericName":"Propofol Fresenius plus lidocaine","slug":"propofol-fresenius-plus-lidocaine","indication":"Other","status":"marketed"},{"name":"Ursolvan","genericName":"Ursolvan","slug":"ursolvan","indication":"Calculus in biliary tract","status":"phase_3"}]}],"pipeline":[{"name":"Rituximab Injection","genericName":"Rituximab Injection","slug":"rituximab-injection","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Gelatin 500 mL","genericName":"Gelatin 500 mL","slug":"gelatin-500-ml","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Propofol Fresenius plus lidocaine","genericName":"Propofol Fresenius plus lidocaine","slug":"propofol-fresenius-plus-lidocaine","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Ursolvan","genericName":"Ursolvan","slug":"ursolvan","phase":"phase_3","mechanism":"Aldo-keto reductase family 1 member C2, CDGSH iron-sulfur domain-containing protein 1, Ectonucleotide pyrophosphatase/phosphodiesterase family member 2","indications":["Calculus in biliary tract","Cholelithiasis Prevention","Primary biliary cirrhosis"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":4,"phaseCounts":{"marketed":3,"phase_3":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}